Vaginal Dryness

1. International Menopause Society. Vaginal atrophy – a change with the menopause [online] [cited 18 August 2022]; Available from URL: https://www.imsociety.org/publication/patient-information leaflet-vaginal-atrophy-a-change-withthe-menopause/.
2. NAMS POSITION STATEMENT. The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society. Menopause 2020;27(9):976 992.
3. Bachman G. Patient education: Vaginal dryness (Beyond the Basics) [online] April 2021 [cited 18 August 2022]; Available from URL: https://www.uptodate.com/contents/vaginal drynessbeyond-the-basics/print.
4. Simon J, Nachtigall L, Gut R, Lang E, Archer DF, Utian W. Effective treatment of vaginal atrophy with an ultra-low-dose estradiol vaginal tablet. Obs & Gynecol 2008;112(5):1053 1060.
5. Johnston SL. Urogenital Concerns. JOGC FEVRIER 2006;S33-S42.
6. Weissmann-Brenner A, Bayevsky T, Yoles I. Compliance to vaginal treatment – tablets versus cream: a retrospective 9 years study. Menopause 2017;24(1):73-76. DOI: 10.1097/GME.0000000000000729.
7. Minkin MJ, Maamari R, Reiter S. Postmenopausal vaginal atrophy: evaluation of treatment with local estrogen therapy. Int J Women’s Health 2013;6:281-288.
8. Mattsson LA, Ericsson A, Bøgelund M, Mamaari R. Women’s preferences toward attributes of local estrogen therapy for the treatment of vaginal atrophy. Maturitas 2013;74:259-263.
9. Dugal R, Hesla K, Sørdal T, Aase KH, Lilleeidet O, Wickstrøm E. Comparison of usefulness of estradiol vaginal tablets and estriol vagitories for the treatment of vaginal atrophy. Acta Obstet Gynecol Scand 2000;79(4):293-297.
10. Portman D, Shulman L, Yeaw J, Zeng S, Uzoigwe C, Maamari R, et al. One-year treatment persistence with local estrogen therapy in postmenopausal women diagnosed as having vaginal atrophy. Menopause. 2015;22(11):1197-203. doi: 10.1097/GME.0000000000000465.
11. Product approved professional information.
12. Reference available on request.

For full prescribing information, please refer to the Professional Information approved by the medicines regulatory authority.

Novo Nordisk (Pty) Ltd. Reg. No.: 1959/000833/07. Marketed by Adcock Ingram Limited. Co. Reg. No. 1949/034385/06. Private Bag
X69, Bryanston, 2021, South Africa. Customer Care: 0860 ADCOCK / 232625. www.adcock.com. 2022082410223366 September 2022.